Last reviewed · How we verify
Anlotinib combined with pemetrexed and carboplatin, phase II
Anlotinib combined with pemetrexed and carboplatin, phase II is a Small molecule drug developed by Chinese Academy of Medical Sciences. It is currently in Phase 1 development. Also known as: APCII.
At a glance
| Generic name | Anlotinib combined with pemetrexed and carboplatin, phase II |
|---|---|
| Also known as | APCII |
| Sponsor | Chinese Academy of Medical Sciences |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma (PHASE2)
- Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC (PHASE2)
- Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC (PHASE1, PHASE2)
- Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE) (PHASE2)
- Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anlotinib combined with pemetrexed and carboplatin, phase II CI brief — competitive landscape report
- Anlotinib combined with pemetrexed and carboplatin, phase II updates RSS · CI watch RSS
- Chinese Academy of Medical Sciences portfolio CI
Frequently asked questions about Anlotinib combined with pemetrexed and carboplatin, phase II
What is Anlotinib combined with pemetrexed and carboplatin, phase II?
Anlotinib combined with pemetrexed and carboplatin, phase II is a Small molecule drug developed by Chinese Academy of Medical Sciences.
Who makes Anlotinib combined with pemetrexed and carboplatin, phase II?
Anlotinib combined with pemetrexed and carboplatin, phase II is developed by Chinese Academy of Medical Sciences (see full Chinese Academy of Medical Sciences pipeline at /company/chinese-academy-of-medical-sciences).
Is Anlotinib combined with pemetrexed and carboplatin, phase II also known as anything else?
Anlotinib combined with pemetrexed and carboplatin, phase II is also known as APCII.
What development phase is Anlotinib combined with pemetrexed and carboplatin, phase II in?
Anlotinib combined with pemetrexed and carboplatin, phase II is in Phase 1.
Related
- Manufacturer: Chinese Academy of Medical Sciences — full pipeline
- Also known as: APCII
- Compare: Anlotinib combined with pemetrexed and carboplatin, phase II vs similar drugs
- Pricing: Anlotinib combined with pemetrexed and carboplatin, phase II cost, discount & access